Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New York Stock Exchange
Pharma
Novo is open to a direct listing on the New York Stock Exchange
Novo is open to making its shares directly available to increasingly crucial U.S. investors.
Donavyn Coffey
Sep 23, 2026 11:28am
Veradermics locks in $256M IPO, shares spike
Feb 5, 2026 10:01am
AstraZeneca plots NYSE listing amid UK industry pullback
Sep 29, 2025 10:05am
J&J's consumer group Kenvue launches $41B IPO
May 4, 2023 10:28am
Stevanato IPO raises $672M to fund biologics, vaccine delivery
Jul 20, 2021 8:20am
Stevanato seeks $100M to invest in biologics, vaccine delivery
Jun 22, 2021 8:10am
